Selected research
Market Structure
Global Drug Containment Solution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Drug Containment Solution market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Drug Containment Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Drug Containment Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Drug Containment Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Drug Containment Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Drug Containment Solution include Stevanato Group, BD, AptarGroup, Hergesheimer AG, Catalent, Inc., West Pharmaceutical Services, Inc., Schott AG, Stearate Group and NIPRO, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Drug Containment Solution market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Drug Containment Solution and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Drug Containment Solution revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Drug Containment Solution market size, projected growth trends, production technologies, key applications, and end-use industries.
Drug Containment Solution Segment by Company
Stevanato Group
BD
AptarGroup
Hergesheimer AG
Catalent, Inc.
West Pharmaceutical Services, Inc.
Schott AG
Stearate Group
NIPRO
Owen Mumford Limited
Psalmed AG
Drug Containment Solution Segment by Type
Vials
Ampoules
Bottles
Drug Containment Solution Segment by Application
Hospitals
Clinics
Home Care Settings
Ambulatory Surgical Centers
Drug Containment Solution Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Containment Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug Containment Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Containment Solution.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Drug Containment Solution in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Drug Containment Solution industry.
Chapter 3: Detailed analysis of Drug Containment Solution companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Containment Solutionrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Vials
- Ampoules
- Bottles
Applications
- Hospitals
- Clinics
- Home Care Settings
- Ambulatory Surgical Centers
Companies covered
- Stevanato Group
- BD
- AptarGroup
- Hergesheimer AG
- Catalent, Inc.
- West Pharmaceutical Services, Inc.
- Schott AG
- Stearate Group
- NIPRO
- Owen Mumford Limited
- Psalmed AG
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Drug Containment Solution Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Vials
- 1.2.3 Ampoules
- 1.2.4 Bottles
- 1.3 Market Analysis by Application
- 1.3.1 Global Drug Containment Solution Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospitals
- 1.3.3 Clinics
- 1.3.4 Home Care Settings
- 1.3.5 Ambulatory Surgical Centers
- 1.4 Global Market Growth Prospects
- 1.5 Global Drug Containment Solution Growth Trends by Region
- 1.5.1 Global Drug Containment Solution Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Drug Containment Solution Market Size by Region (2021-2026)
- 1.5.3 Drug Containment Solution Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Drug Containment Solution Market Dynamics
- 2.1 Drug Containment Solution Industry Trends
- 2.2 Drug Containment Solution Industry Drivers
- 2.3 Drug Containment Solution Industry Opportunities and Challenges
- 2.4 Drug Containment Solution Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Drug Containment Solution Revenue by Company (2021-2026)
- 3.2 Global Drug Containment Solution Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Drug Containment Solution Key Company Head office and Area Served
- 3.4 Global Drug Containment Solution Company, Product Type & Application
- 3.5 Global Drug Containment Solution Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Drug Containment Solution Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Drug Containment Solution Players Market Share by Revenue in 2025
- 3.6.3 2025 Drug Containment Solution Tier 1, Tier 2, and Tier 3
4 Drug Containment Solution Market by Type
- 4.1 Global Drug Containment Solution Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Drug Containment Solution Market Size by Type (2021-2032)
- 4.3 Global Drug Containment Solution Market Size Share by Type (2021-2032)
5 Drug Containment Solution Market by Application
- 5.1 Global Drug Containment Solution Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Drug Containment Solution Market Size by Application (2021-2032)
- 5.3 Global Drug Containment Solution Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Stevanato Group
- 6.1.1 Stevanato Group Company Information
- 6.1.2 Stevanato Group Business Overview
- 6.1.3 Stevanato Group Drug Containment Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Stevanato Group Drug Containment Solution Product Portfolio
- 6.1.5 Stevanato Group Recent Developments
- 6.2 BD
- 6.2.1 BD Company Information
- 6.2.2 BD Business Overview
- 6.2.3 BD Drug Containment Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 BD Drug Containment Solution Product Portfolio
- 6.2.5 BD Recent Developments
- 6.3 AptarGroup
- 6.3.1 AptarGroup Company Information
- 6.3.2 AptarGroup Business Overview
- 6.3.3 AptarGroup Drug Containment Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 AptarGroup Drug Containment Solution Product Portfolio
- 6.3.5 AptarGroup Recent Developments
- 6.4 Hergesheimer AG
- 6.4.1 Hergesheimer AG Company Information
- 6.4.2 Hergesheimer AG Business Overview
- 6.4.3 Hergesheimer AG Drug Containment Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Hergesheimer AG Drug Containment Solution Product Portfolio
- 6.4.5 Hergesheimer AG Recent Developments
- 6.5 Catalent, Inc.
- 6.5.1 Catalent, Inc. Company Information
- 6.5.2 Catalent, Inc. Business Overview
- 6.5.3 Catalent, Inc. Drug Containment Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Catalent, Inc. Drug Containment Solution Product Portfolio
- 6.5.5 Catalent, Inc. Recent Developments
- 6.6 West Pharmaceutical Services, Inc.
- 6.6.1 West Pharmaceutical Services, Inc. Company Information
- 6.6.2 West Pharmaceutical Services, Inc. Business Overview
- 6.6.3 West Pharmaceutical Services, Inc. Drug Containment Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 West Pharmaceutical Services, Inc. Drug Containment Solution Product Portfolio
- 6.6.5 West Pharmaceutical Services, Inc. Recent Developments
- 6.7 Schott AG
- 6.7.1 Schott AG Company Information
- 6.7.2 Schott AG Business Overview
- 6.7.3 Schott AG Drug Containment Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Schott AG Drug Containment Solution Product Portfolio
- 6.7.5 Schott AG Recent Developments
- 6.8 Stearate Group
- 6.8.1 Stearate Group Company Information
- 6.8.2 Stearate Group Business Overview
- 6.8.3 Stearate Group Drug Containment Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Stearate Group Drug Containment Solution Product Portfolio
- 6.8.5 Stearate Group Recent Developments
- 6.9 NIPRO
- 6.9.1 NIPRO Company Information
- 6.9.2 NIPRO Business Overview
- 6.9.3 NIPRO Drug Containment Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 NIPRO Drug Containment Solution Product Portfolio
- 6.9.5 NIPRO Recent Developments
- 6.10 Owen Mumford Limited
- 6.10.1 Owen Mumford Limited Company Information
- 6.10.2 Owen Mumford Limited Business Overview
- 6.10.3 Owen Mumford Limited Drug Containment Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Owen Mumford Limited Drug Containment Solution Product Portfolio
- 6.10.5 Owen Mumford Limited Recent Developments
- 6.11 Psalmed AG
- 6.11.1 Psalmed AG Company Information
- 6.11.2 Psalmed AG Business Overview
- 6.11.3 Psalmed AG Drug Containment Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Psalmed AG Drug Containment Solution Product Portfolio
- 6.11.5 Psalmed AG Recent Developments
7 North America
- 7.1 North America Drug Containment Solution Market Size (2021-2032)
- 7.2 North America Drug Containment Solution Market Size by Type
- 7.2.1 North America Drug Containment Solution Market Size by Type (2021-2026)
- 7.2.2 North America Drug Containment Solution Market Size by Type (2027-2032)
- 7.2.3 North America Drug Containment Solution Market Share by Type (2021-2032)
- 7.3 North America Drug Containment Solution Market Size by Application
- 7.3.1 North America Drug Containment Solution Market Size by Application (2021-2026)
- 7.3.2 North America Drug Containment Solution Market Size by Application (2027-2032)
- 7.3.3 North America Drug Containment Solution Market Share by Application (2021-2032)
- 7.4 North America Drug Containment Solution Market Size by Country
- 7.4.1 North America Drug Containment Solution Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Drug Containment Solution Market Size by Country (2021-2026)
- 7.4.3 North America Drug Containment Solution Market Size by Country (2027-2032)
- 7.4.4 North America Drug Containment Solution Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Drug Containment Solution Market Size (2021-2032)
- 8.2 Europe Drug Containment Solution Market Size by Type
- 8.2.1 Europe Drug Containment Solution Market Size by Type (2021-2026)
- 8.2.2 Europe Drug Containment Solution Market Size by Type (2027-2032)
- 8.2.3 Europe Drug Containment Solution Market Share by Type (2021-2032)
- 8.3 Europe Drug Containment Solution Market Size by Application
- 8.3.1 Europe Drug Containment Solution Market Size by Application (2021-2026)
- 8.3.2 Europe Drug Containment Solution Market Size by Application (2027-2032)
- 8.3.3 Europe Drug Containment Solution Market Share by Application (2021-2032)
- 8.4 Europe Drug Containment Solution Market Size by Country
- 8.4.1 Europe Drug Containment Solution Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Drug Containment Solution Market Size by Country (2021-2026)
- 8.4.3 Europe Drug Containment Solution Market Size by Country (2027-2032)
- 8.4.4 Europe Drug Containment Solution Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Drug Containment Solution Market Size (2021-2032)
- 9.2 China Drug Containment Solution Market Size by Type
- 9.2.1 China Drug Containment Solution Market Size by Type (2021-2026)
- 9.2.2 China Drug Containment Solution Market Size by Type (2027-2032)
- 9.2.3 China Drug Containment Solution Market Share by Type (2021-2032)
- 9.3 China Drug Containment Solution Market Size by Application
- 9.3.1 China Drug Containment Solution Market Size by Application (2021-2026)
- 9.3.2 China Drug Containment Solution Market Size by Application (2027-2032)
- 9.3.3 China Drug Containment Solution Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Drug Containment Solution Market Size (2021-2032)
- 10.2 Asia Drug Containment Solution Market Size by Type
- 10.2.1 Asia Drug Containment Solution Market Size by Type (2021-2026)
- 10.2.2 Asia Drug Containment Solution Market Size by Type (2027-2032)
- 10.2.3 Asia Drug Containment Solution Market Share by Type (2021-2032)
- 10.3 Asia Drug Containment Solution Market Size by Application
- 10.3.1 Asia Drug Containment Solution Market Size by Application (2021-2026)
- 10.3.2 Asia Drug Containment Solution Market Size by Application (2027-2032)
- 10.3.3 Asia Drug Containment Solution Market Share by Application (2021-2032)
- 10.4 Asia Drug Containment Solution Market Size by Country
- 10.4.1 Asia Drug Containment Solution Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Drug Containment Solution Market Size by Country (2021-2026)
- 10.4.3 Asia Drug Containment Solution Market Size by Country (2027-2032)
- 10.4.4 Asia Drug Containment Solution Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Drug Containment Solution Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Drug Containment Solution Market Size by Type
- 11.2.1 South America, Middle East & Africa Drug Containment Solution Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Drug Containment Solution Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Drug Containment Solution Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Drug Containment Solution Market Size by Application
- 11.3.1 South America, Middle East & Africa Drug Containment Solution Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Drug Containment Solution Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Drug Containment Solution Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Drug Containment Solution Market Size by Country
- 11.4.1 South America, Middle East & Africa Drug Containment Solution Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Drug Containment Solution Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Drug Containment Solution Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Drug Containment Solution Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst